Novo Nordisk
NVO
NVO
1,195 hedge funds and large institutions have $23.2B invested in Novo Nordisk in 2023 Q2 according to their latest regulatory filings, with 142 funds opening new positions, 444 increasing their positions, 392 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $486M | Put options by funds: $448M
0.32% more ownership
Funds ownership: 16.38% → 16.71% (+0.32%)
16% less funds holding in top 10
Funds holding in top 10: 56 → 47 (-9)
Holders
1,195
Holding in Top 10
47
Calls
$486M
Puts
$448M
Top Buyers
| 1 | +$190M | |
| 2 | +$124M | |
| 3 | +$104M | |
| 4 |
Lazard Asset Management
New York
|
+$85.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.1M |
Top Sellers
| 1 | -$578M | |
| 2 | -$234M | |
| 3 | -$106M | |
| 4 |
SIG
Senator Investment Group
New York
|
-$67.6M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$42.1M |